Nina Odan

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Metastatic Breast Cancer

Affordable Care Act

Patient Reported

Cross Sectional

Top Venues

Breast cancer (Tokyo, Japan)

Breast cancer : basic and clinical research

This page only lists publications with an associated author ORCID identifier.

Publications

Tomoe Taji, Nina Odan, Yuki Kataoka, Mako Ikeda, Ai Yamaguchi, Eiji Suzuki, Hirofumi Suwa
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study. Breast cancer (Tokyo, Japan) (2022)
Tomoe Taji, Nina Odan, Yuki Kataoka, Mako Ikeda, Ai Yamaguchi, Eiji Suzuki, Hirofumi Suwa
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study. Breast cancer (Tokyo, Japan) 30 (2) (2022)
Tomoe Taji, Nina Odan, Yuki Kataoka, Mako Ikeda, Ai Yamaguchi, Eiji Suzuki, Hirofumi Suwa
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study. Breast cancer (Tokyo, Japan) 30 (2) (2022)
Tomoe Taji, Nina Odan, Yuki Kataoka, Mako Ikeda, Ai Yamaguchi, Eiji Suzuki, Hirofumi Suwa
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study. Breast cancer (Tokyo, Japan) 30 (2) (2022)
Tomoe Taji, Nina Odan, Yuki Kataoka, Mako Ikeda, Ai Yamaguchi, Eiji Suzuki, Hirofumi Suwa
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study. Breast cancer (Tokyo, Japan) 30 (2) (2022)
Nina Odan, Yuichiro Kikawa, Hajime Matsumoto, Junya Minohata, Hirofumi Suwa, Takashi Hashimoto, Toshitaka Okuno, Masaru Miyashita, Masaru Saito, Kazuhiko Yamagami, Shintaro Takao
Real-World Outcomes of Treating Advanced Breast Cancer Patients With Palbociclib: A Multicenter Retrospective Cohort Study in Japan-The KBCOG-14 Study. Breast cancer : basic and clinical research 14 (2020)